Full-Time

Area Sales Director

Chronic Therapies

Posted on 9/17/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$167.4k - $279k/yr

Trenton, NJ, USA + 2 more

More locations: Hartford, CT, USA | New York, NY, USA

Remote

Candidates should ideally be located in the Northeast region.

US Citizenship Required

Category
Sales & Account Management (2)
,
Requirements
  • Bachelor’s degree and a minimum of 3yrs of recent in office-based physician sales leadership experience with a proven record of success, OR High school diploma and a minimum of 6yrs of recent in office-based physician sales leadership experience with a proven record of success.
  • Results-oriented mindset with expertise in coaching and developing people
  • Ability to lead, manage, and grow a high-volume, high-dollar business
  • Motivation and leadership skills that create a positive working environment that challenges team members to help each other become successful
  • Expertise in analyzing sales data to identify issues, trends, or exceptions to drive improvement of results and find solutions
  • Leadership skills when working with cross-functional teams
  • Experience in developing long-standing relationships with high-potential accounts and key opinion leaders
  • Understanding of financials (P&L management)
  • Candidates must be able to successfully pass background check and drug screening
Responsibilities
  • Achieves all sales performance and activity goals by therapy for geographical responsibility.
  • Trains, coaches, develops, and supervises chronic therapies sales team.
  • Develops and directs the implementation of the chronic therapies sales plan.
  • Plans, forecasts, and implements the Area resources appropriately, including staffing, budget, and key initiatives.
  • Serves as an active member of the chronic business sales leadership team and other cross-functional teams to provide a field perspective.
  • Recruits, interviews, hires, and on-boards the chronic therapies sales team in geographic area of responsibility.
  • Maintains high visibility with the chronic therapies sales team within the Area through field days and attendance at regional meetings/conferences.
  • Develops and maintains team spirit and enthusiasm to achieve the greatest impact on chronic sales through verbal and written communication.
  • Develop and improve the sales presentations of the chronic therapies sales team and lead by example by demonstrating success in creating new business.
  • Collaborates with Market Access team to identify and implement Area pull-through opportunities.
  • Partners with Operations to build strong relationships with branch management to ensure sales efforts are supported by branch services and sales efforts are aligned with branch capabilities.
  • Collaborates with the acute therapies sales leaders to ensure a synergistic approach to customers.
  • Identifies Key Opinion Leaders within the Area and develops business relationships to strategically leverage these influential thought leaders.
  • Identifies and creates partnership opportunities with targeted physician group practices.
  • Leads the recruitment and management of Advisory Board Members within the Area.
  • Works cross-functionally to develop and implement the Ambulatory Infusion Suite strategy within the Area.
  • Establish and develop relationships with the Professional Medical Societies within the Area and create strategies to drive business results.
  • Identifies opportunities and develops relationships with targeted Patient Advocacy groups to increase business results.
  • Monitors Area trends including industry, market, competitor, and sales to develop appropriate sales plans to maximize market opportunities and/or address market issues.
  • Must be an expert in the individual market dynamics within the Area as well as in the complex disease states that Option Care Health services.
  • Provides input into the chronic therapies field sales team compensation plan.
  • Monitors and manages sales team activity to ensure appropriate focus and effort on targeted priority offices and accounts.
  • Ensure that all employees in the Area are compliant with all Option Care Health policies, procedures, and guidelines.
Desired Qualifications
  • MBA in Business Administration with at least 10 years of pharmaceutical or healthcare sales experience
  • Previous home healthcare experience.
  • Participation in task forces and/or initiative teams demonstrating impact above immediate span of control
  • Background in selling to Neurology, Gastroenterology, and/or Allergy/Immunology specialties
  • Understanding of billing and reimbursement procedures for medical offices and hospitals (Commercial Insurance, Medicare Part B & D, Fee for Service Medicaid, Managed Medicaid)

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Expanded revolving credit facility to $850 million enables M&A flexibility.
  • Increased share repurchase authorization to $1 billion signals management confidence.
  • Operating cash flow exceeds $340 million in 2026, growing over 30%.

What critics are saying

  • Chronic Inflammatory Disease portfolio reset causes $55 million revenue headwind through 2026.
  • Stelara biosimilars and Inflation Reduction Act cut gross profit by $25-35 million.
  • EEOC pregnancy discrimination lawsuit triggers fines and talent exodus by 2027.

What makes Option Care Health unique

  • Largest national independent provider of home and alternate site infusion services.
  • Serves over 315,000 unique patients with high-quality infusion therapy options.
  • Selected by Quince Therapeutics for specialty infusion of lead asset eDSP.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE